References
- Fischl M A, Richman D D, Grieco M H, Gottlieb M S, Volberding P A, Laskin O L, Leedom J M, Groopman J E, Mildvan D, Schooley R T, Jackson G G, Durack D T, King D, The A ZT, Group Collaborative Working. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind placebo-controlled trial. N Engl J Med 1987; 317: 185–191
- Volberding P A, Lagakos S W, Koch M A, Pettinelli C, Myers M W, Booth D K, Balfour H H, Reichman R C, Bartlett J A, Hirsch M S, Murphy R L, Hardy W D, Soeiro R, Fischl M A, Bartlett J G, Merigan T C, Hyslop N E, Richman D D, Valentine F T, Corey L. The AIDS Clinical Trials Group of the National Institute of Allergy and Infectious Diseases Zidovudine in asymptomatic human immunodeficiency virus infection. A controlled trial in persons with fewer than 500 CD4-positive cells per cubic millimeter. N Engl J Med 1990; 322: 941–949
- Larder B A, Darby G, Richman D D. HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy. Science 1989; 243: 1731–1734
- Nielsen C, Gøtzsche P C, Nielsen C M, Gerstoft J, Vestergaard B F. Development of resistance to zidovudine in HIV strains isolated from CD4+ lymphocytes and plasma during therapy. Antiviral Res 1992; 18: 303–316
- Dournon E, Matheron S, Rozenbaum W, Gharakhanian S, Michon C, Girard P M, Peronne C, Salmon D, de Truchis P, Leport C, Bouvet E, Dazza M C, Levacher M, Regnier B, The Claude Bernard Hospital AZT Study Group. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex. Lancet 1988; 2: 1297–1302
- Nordic Medical Research Councils' HIV Therapy Group. Double-blind dose-response study of zidovudine in AIDS and advanced HIV infection. BMJ 1992; 304: 13–17
- Richmann D D, Grimes J M, Lagakos S W. Effect on stage of disease and drug dose on zidovudine susceptibilities of isolates of human immunodeficiency virus. J Acquir Immune Defic Syndr 1990; 3: 743–746
- Fischl M A, Parker C B, Pettinelli C, Wulfsohn M, Hirsch M S, Collier A C, Antoniskis D, Ho M, Richman D D, Fuchs E, Merigan T C, Reichman R C, Gold J, Steigbigel N, The AIDS Clinical Trials Group. A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. N Engl J Med 1990; 323: 1009–1014